Clinical Trial Update: Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study [Phase 4]

View source ↗

Summary

Phase 4 trial updating the use of tenofovir disoproxil fumarate (TDF) 300 mg as rescue therapy in chronic hepatitis B with prior nucleos(t)ide analogue failure;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2019-11-04